(Q51733222)

English

Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.

scientific article published on 13 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

reactive oxygen species

1 reference

based on heuristic

inferred from title

1

object named as

Amy Barton Pai

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

author name string

Todd Conner

2

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

Charles R McQuade

3

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

Jonathan Olp

4

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

Paul Hicks

5

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

publication date

13 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

24

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

4

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

603-613

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Physicochemical properties of ferumoxytol, a new intravenous iron preparation.

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

A fluorescence-based one-step assay for serum non-transferrin-bound iron

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Administration of parenteral iron and mortality among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis.

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Time-dependent associations between iron and mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Plasma pharmacokinetics of two consecutive doses of ferumoxytol in healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Haemodialysis induces mitochondrial dysfunction and apoptosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Labile iron in parenteral iron formulations: a quantitative and comparative study

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Hepcidin--a potential novel biomarker for iron status in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS10534-011-9409-6

21 January 2018

Identifiers

10.1007/S10534-011-9409-6

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/21229380

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51733222&oldid=2211142120"